The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.
The consequences of the anti-vaccine movement reach beyond today’s controversies. Scott Gottlieb is a former commissioner of ...
Biogen’s litifilimab has received Breakthrough Therapy Designation from the US FDA to treat cutaneous lupus erythematosus ...
Your face might be revealing a hidden vitamin D deficiency through subtle changes like persistent dark circles and ...
Your body might be sending you hints about your health.
Beauty Cooks Kisses on MSN
What foods to avoid with canker sores and what to eat for faster healing
We’ve all been there: you’re about to enjoy a delicious meal, but one tiny, painful spot in your mouth turns every bite into ...
Submissions are supported by data from the Phase 3 Viti-Up clinical studies demonstrating upadacitinib achieved the co-primary endpoints of at least a 50% improvement ...
writes on health, immigration, motherhood, and identity. Once a hater of makeup, she and her three children now use eyeshadow ...
Picture living with severe pelvic pain so intense that it interferes with your work, school, time with family, daily life — ...
Amgen’s bad luck in lupus may finally be coming to an end. Daxdilimab, a monoclonal antibody acquired from Horizon ...
Feb 3 (Reuters) - AstraZeneca said on Tuesday that the U.S. health regulator had rejected its application for an ...
Subcutaneous anifrolumab is superior to placebo in multiple systemic lupus erythematosus disease activity measures at 52 weeks, according to data published in Arthritis & Rheumatology.“As a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results